A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 27 483.5996 INR -0.07% Market Closed
Market Cap: 584B INR
Have any thoughts about
Abbott India Ltd?
Write Note

Operating Margin
Abbott India Ltd

23.9%
Current
22%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.9%
=
Operating Profit
14.2B
/
Revenue
59.3B

Operating Margin Across Competitors

Country IN
Market Cap 584B INR
Operating Margin
24%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 749.7B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 372B USD
Operating Margin
28%
Country US
Market Cap 257.3B USD
Operating Margin
34%
Country CH
Market Cap 201.7B CHF
Operating Margin
32%
Country UK
Market Cap 163B GBP
Operating Margin
21%
Country CH
Market Cap 179.6B CHF
Operating Margin
31%
Country US
Market Cap 146B USD
Operating Margin
22%
No Stocks Found

Abbott India Ltd
Glance View

Market Cap
584B INR
Industry
Pharmaceuticals

Abbott India Ltd, a subsidiary of the global healthcare giant Abbott Laboratories, is a key player in the Indian pharmaceutical and healthcare industry, with a legacy that spans over seven decades. The company focuses on developing and distributing a wide range of healthcare products, including prescription medications, nutritional supplements, and diagnostics. With a strong emphasis on innovation and quality, Abbott India has established a robust portfolio of well-known brands in therapeutic areas such as cardiology, diabetes care, and women's health. Its consistent commitment to research and development, coupled with the backing of its parent company, positions Abbott India as a formidable competitor in a rapidly growing market that is increasingly shifting towards preventive care and advanced therapies. In recent years, Abbott India has demonstrated impressive growth, benefiting from rising healthcare demand driven by an expanding middle class and increasing health awareness across the country. The company's strategic investments in manufacturing, distribution, and digital health technologies enhance its ability to reach a broader consumer base and improve patient accessibility. Additionally, Abbott's strong financial health, characterized by steady revenue growth and dividend payments, makes it an attractive option for investors seeking stability and long-term value. As the Indian healthcare landscape evolves, Abbott India is poised to capitalize on emerging trends, reinforcing its reputation as a trusted brand while delivering impactful solutions to its customers.

ABBOTINDIA Intrinsic Value
16 226.7009 INR
Overvaluation 41%
Intrinsic Value
Price
A

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.9%
=
Operating Profit
14.2B
/
Revenue
59.3B
What is the Operating Margin of Abbott India Ltd?

Based on Abbott India Ltd's most recent financial statements, the company has Operating Margin of 23.9%.